As Rite Aid (RAD) Share Value Declined, Greenlight Capital Has Trimmed Its Holding; As Abiomed (ABMD) Market Valuation Rose, Essex Woodlands Health Ventures Has Trimmed Its Stake by $84.53 Million

February 17, 2018 - By Clifton Ray

David Einhorn decreased its stake in Rite Aid Corp (RAD) by 8.94% based on its latest 2017Q3 regulatory filing with the SEC. Greenlight Capital Inc sold 1.50 million shares as the company’s stock declined 41.75% while stock markets rallied. The hedge fund run by David Einhorn held 15.28 million shares of the medical and nursing services company at the end of 2017Q3, valued at $29.95M, down from 16.78 million at the end of the previous reported quarter. Greenlight Capital Inc who had been investing in Rite Aid Corp for a number of months, seems to be less bullish one the $2.23B market cap company. The stock increased 2.40% or $0.05 during the last trading session, reaching $2.13. About 9.44 million shares traded. Rite Aid Corporation (NYSE:RAD) has declined 55.18% since February 17, 2017 and is downtrending. It has underperformed by 71.88% the S&P500.

Essex Woodlands Health Ventures Inc decreased its stake in Abiomed Inc (ABMD) by 34.7% based on its latest 2017Q3 regulatory filing with the SEC. Essex Woodlands Health Ventures Inc sold 503,182 shares as the company’s stock rose 15.32% with the market. The hedge fund held 946,818 shares of the health care company at the end of 2017Q3, valued at $159.63M, down from 1.45M at the end of the previous reported quarter. Essex Woodlands Health Ventures Inc who had been investing in Abiomed Inc for a number of months, seems to be less bullish one the $11.86B market cap company. The stock increased 2.57% or $6.7 during the last trading session, reaching $267.74. About 512,496 shares traded or 42.21% up from the average. ABIOMED, Inc. (NASDAQ:ABMD) has risen 40.97% since February 17, 2017 and is uptrending. It has outperformed by 24.27% the S&P500.

Investors sentiment decreased to 1.3 in 2017 Q3. Its down 0.13, from 1.43 in 2017Q2. It dropped, as 27 investors sold ABMD shares while 89 reduced holdings. 55 funds opened positions while 96 raised stakes. 38.51 million shares or 1.21% less from 38.99 million shares in 2017Q2 were reported. Victory Management Inc reported 0% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Jpmorgan Chase has invested 0% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Amp Capital Limited reported 4,400 shares. Moreover, Coe Mgmt Ltd Liability Corp has 1.07% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 6,110 shares. Janney Montgomery Scott Limited Liability Co holds 2,903 shares. State Of Tennessee Treasury Department accumulated 30,000 shares. Loomis Sayles And Limited Partnership has 0.01% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 28,594 shares. First Allied Advisory Svcs accumulated 1,402 shares. Parametric Associate Ltd Limited Liability Company holds 0.01% or 45,697 shares. Meeder Asset Mgmt has invested 0% in ABIOMED, Inc. (NASDAQ:ABMD). Rmb Capital Mgmt Limited Liability Company holds 45,969 shares or 0.2% of its portfolio. Marshall Wace Llp holds 0.07% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 8,704 shares. 4,302 were reported by Sg Americas Secs Limited Liability Corp. Schroder Invest Mngmt Gp reported 13,284 shares. Mason Street Limited Liability Co owns 20,795 shares or 0.09% of their US portfolio.

Among 14 analysts covering Abiomed (NASDAQ:ABMD), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Abiomed had 32 analyst reports since August 4, 2015 according to SRatingsIntel. As per Thursday, April 6, the company rating was upgraded by PiperJaffray. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Jefferies on Thursday, September 21. The rating was maintained by Leerink Swann with “Outperform” on Wednesday, May 4. The firm has “Buy” rating given on Tuesday, August 9 by Jefferies. Jefferies maintained it with “Buy” rating and $16500 target in Thursday, August 3 report. The stock has “Buy” rating by Jefferies on Thursday, February 1. The company was initiated on Wednesday, December 7 by Guggenheim. The rating was maintained by Piper Jaffray on Thursday, January 4 with “Buy”. The firm earned “Buy” rating on Tuesday, June 6 by Jefferies. Piper Jaffray maintained the shares of ABMD in report on Wednesday, August 5 with “Hold” rating.

Since August 15, 2017, it had 0 insider purchases, and 3 selling transactions for $5.53 million activity. Greenfield Andrew J had sold 11,282 shares worth $1.91 million on Saturday, September 30. The insider THOMAS PAUL sold 10,000 shares worth $1.55 million.

Investors sentiment increased to 0.97 in 2017 Q3. Its up 0.19, from 0.78 in 2017Q2. It is positive, as 57 investors sold RAD shares while 77 reduced holdings. 43 funds opened positions while 87 raised stakes. 513.41 million shares or 4.79% less from 539.25 million shares in 2017Q2 were reported. Los Angeles Capital Mngmt Equity Rech Inc stated it has 27,490 shares or 0% of all its holdings. Moreover, State Street Corp has 0% invested in Rite Aid Corporation (NYSE:RAD) for 16.07 million shares. Da Davidson & invested in 30,700 shares. Zurcher Kantonalbank (Zurich Cantonalbank) owns 47,579 shares or 0% of their US portfolio. Fny Managed Accounts Lc has 219,600 shares. Tru Of Vermont owns 9,000 shares. Tradewinds Capital Management Ltd Llc accumulated 500 shares. Vantage Invest Advsrs Ltd Com owns 1,000 shares. Css Llc Il holds 0.15% in Rite Aid Corporation (NYSE:RAD) or 1.56M shares. Panagora Asset Mgmt holds 0% or 60,357 shares. 32,004 are held by Mitsubishi Ufj Tru & Bk. Equitec Proprietary Mkts Ltd Company stated it has 0.06% in Rite Aid Corporation (NYSE:RAD). Hilton Cap Mngmt Ltd Liability Corporation invested in 0.03% or 85,000 shares. Integral Derivatives Limited has 29,500 shares. Winslow Evans Crocker Inc reported 0% stake.

Among 14 analysts covering Rite Aid (NYSE:RAD), 2 have Buy rating, 2 Sell and 10 Hold. Therefore 14% are positive. Rite Aid had 24 analyst reports since August 6, 2015 according to SRatingsIntel. Evercore reinitiated Rite Aid Corporation (NYSE:RAD) rating on Friday, June 30. Evercore has “Underperform” rating and $2.50 target. The firm has “Neutral” rating given on Friday, October 6 by Mizuho. The stock of Rite Aid Corporation (NYSE:RAD) earned “Hold” rating by Loop Capital on Friday, September 29. As per Friday, April 8, the company rating was downgraded by Deutsche Bank. Credit Suisse downgraded the stock to “Neutral” rating in Thursday, October 29 report. The firm has “Neutral” rating by JP Morgan given on Friday, November 13. On Thursday, August 13 the stock rating was initiated by Bank of America with “Buy”. The rating was downgraded by Guggenheim on Wednesday, April 26 to “Neutral”. The rating was initiated by Loop Capital Markets with “Hold” on Monday, September 11. Vetr downgraded the stock to “Buy” rating in Thursday, August 6 report.

Since October 3, 2017, it had 0 buys, and 1 insider sale for $58,915 activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>